acquired
Stage
2013
Founded
1
Investors
About
HighLife developed a transcatheter mitral valve replacement (TMVR) system designed to treat patients with mitral regurgitation. The company was acquired by Boston Scientific in 2019.
Explore HighLife's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.